SOUTH EASTON, Mass., Nov. 6, 2013 /PRNewswire/ -- Pressure BioSciences, Inc. (PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Third Quarter 2013 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone (live) or through a replay on the Company's website. The teleconference information is provided below:
Date: Thursday, November 7, 2013
Time: 4:15 PM Eastern Standard Time (EST)
To attend this teleconference via telephone:
Dial-in: (800) 391-2548 (U.S.); (866) 627-1646 (Canada); (302) 709-8328 (International)
Conference ID: 861819
For those unable to participate in the live teleconference, a replay will be available approximately one hour after the call and will be accessible through the Company's website for 30 days.
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. ("PBI") (PBIO) is focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology ("PCT"). PCT is a patented, enabling technology platform with multiple applications in the estimated $6 billion life sciences sample preparation market. PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. PBI currently focuses its efforts on the development and sale of PCT-enhanced sample preparation systems (instruments and consumables) for mass spectrometry, biomarker discovery, bio-therapeutics characterization, vaccine development, soil and plant biology, forensics, histology, and counter-bioterror applications.
For more information about PBI and this press release, please click on the following link:
Richard T. Schumacher, President & CEO
Pressure BioSciences, Inc.
Richard P. Thomley, Acting CFO
- Company Earnings